The MSQoL was funded by the Wellcome Foundation and developed by Galen Research, as part of an international research study which was conducted in eight countries, with initial work conducted in the UK and US.
[4] Scores on the MSQoL were also found to be consistent with another measure of well-being as well as the perceived severity of the affliction for the patients.
[7] The MSQoL has also been utilized by pharmaceutical companies in order to test whether a given therapy or medication is effective in treating migraines.
The MSQoL has been used in the assessment of the effect of nadolol and topiramate,[8] regular water intake[9] and using migraine patients as trainers in preventive attack management.
[10] Different scores on the MSQoL taken before and after the trial infer a change in the patient's quality of life.